Frank G Martin

US Patent:

56487533, Jul 15, 1997

Filed:

Nov 22, 1994

Appl. No.:

8/343668

Inventors:

Frank A. Martin - Santa Clara CA

International Classification:

G08B 300

US Classification:

3403241

Abstract:

An interchangeable sound effect device which incorporates and plays sound effects that have been digitally recorded on interchangeable sound cartridges. This device is designed to be used with entertainment and educational type products such as toys, dolls, figurines, books and instructional guides. The sound effect device employs an infrared receiver housed within a durable encasement which straps around the user's waist or is embedded within the doll, figurine, toy, or book. The receiver unit contains an infrared detector, an electronic diving means, an audio speaker, and a sound cartridge that rests within a sound cartridge chamber. The sound cartridge contains a sound enabler chip that stores, in digital form, a number of prerecorded sound effects. In addition, the user can easily remove the sound cartridge and insert one of many other sound cartridges each containing a different set of sound effects. Finally, the sound effect device uses an infrared transmitter that attaches to an adjustable glove.

US Patent:

62363050, May 22, 2001

Filed:

Apr 4, 2000

Appl. No.:

9/542208

Inventors:

Frank A. Martin - Santa Clara CA

International Classification:

G08B 310

US Classification:

3403843

Abstract:

An interchangeable sound effect device (1) that incorporates and plays sound effects that have been digitally recorded on interchangeable sound cartridges (4). This device (1) is designed to be used with entertainment and educational type products such as toys, dolls, figurines, books and instructional guides. The sound effect device (1) employs an infrared receiver (28) housed within a durable encasement that straps around the user's waist or is embedded within the doll, figurine, toy, or book. The receiver unit (28) contains an infrared detector (44), an electronic diving means (60), an audio speaker (52), and a sound cartridge (4) that rests within a sound cartridge chamber (32). The sound cartridge (4) contains a sound enabler chip (12) that stores, in digital form, a number of prerecorded sound effects. In addition, the user can easily remove the sound cartridge (4) and insert one of many other sound cartridges each containing a different set of sound effects.

US Patent:

60466707, Apr 4, 2000

Filed:

Dec 14, 1998

Appl. No.:

9/211299

Inventors:

Frank A. Martin - Santa Clara CA

International Classification:

G08B 310

US Classification:

3403843

Abstract:

An interchangeable sound effect device (1) which incorporates and plays sound effects that have been digitally recorded on interchangeable sound cartridges (4). This device (1) is designed to be used with entertainment and educational type products such as toys, dolls, figurines, books and instructional guides. The sound effect device (1) employs an infrared receiver (28) housed within a durable encasement which straps around the user's waist or is embedded within the doll, figurine, toy, or book. The receiver unit (28) contains an infrared detector (44), an electronic diving means (60), an audio speaker (52), and a sound cartridge (4) that rests within a sound cartridge chamber (32). The sound cartridge (4) contains a sound enabler chip (12) that stores, in digital form, a number of prerecorded sound effects. In addition, the user can easily remove the sound cartridge (4) and insert one of many other sound cartridges each containing a different set of sound effects.

US Patent:

44290080, Jan 31, 1984

Filed:

Dec 10, 1981

Appl. No.:

6/329211

Inventors:

Frank J. Martin - San Francisco CA
Demetrios P. Papahadjopoulos - Lafayette CA
Wayne L. Hubbell - Orinda CA

Assignee:

The Regents of the University of California - Berkeley CA

International Classification:

B01J 1302
B32B 902

US Classification:

4284022

Abstract:

Liposomes are provided which have a plurality of thiol reactive groups extending outward of the liposomal bilayer. The liposomes form stable covalent bonds with ligands having thiol groups, such as Fab' fragments. Particularly preferred liposomes include maleimide moieties as the thiol reactive groups. The thiol reactive liposomes are usefully employed in agglutination assays, such as blood typing and binding inhibitions, and targeting to specific cells.

US Patent:

20160304596, Oct 20, 2016

Filed:

Apr 22, 2016

Appl. No.:

15/136832

Inventors:

- Thousand Oaks CA, US
- Princeton NJ, US
Haichun HUANG - Fremont CA, US
Heather INOUE - Oak Park CA, US
Tie J. ZHANG - Thousand Oaks CA, US
Frank MARTIN - Newbury Park CA, US

Assignee:

AMGEN INC. - Thousand Oaks CA
E.R. SQUIBB & SONS, L.L.C. - Princeton NJ

International Classification:

C07K 16/22
G01N 33/74

Abstract:

This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.

US Patent:

20160237147, Aug 18, 2016

Filed:

Jan 19, 2016

Appl. No.:

15/000771

Inventors:

- Thousand Oaks CA, US
- Princeton NJ, US
Haichun Huang - Fremont CA, US
Heather Inoue - Oak Park CA, US
Tie J. Zhang - Thousand Oaks CA, US
Frank Martin - Newbury Park CA, US

International Classification:

C07K 16/22

Abstract:

This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize the function of NGF thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing NGF function, and particularly for treating NGF-related disorders (e.g., chronic pain) by administering a pharmaceutically effective amount of anti-NGF antibodies. Methods of detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.